Jennifer E. Cook, Director at Jazz Pharmaceuticals plc (JAZZ), sold 840 shares at $154.68 ($130K) on 2022-12-02, disclosed to the SEC on 2022-12-06.
Open-market sale of $130k JAZZ by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $154.68 | 420 | $65K | 50.0% |
| 2 | $154.68 | 420 | $65K | 50.0% |
| Total | $154.68 avg | 840 | $130K | 100% |
| Filing → |
| BBIO | SELL | 2026-06-17 | $6.0M | — | Filing → |
| DNLI | SELL | 2024-06-10 | $32K | — | Filing → |
| JAZZ | SELL | 2023-12-06 | $50K | — | Filing → |